In laboratories across the world, cancer cells have long been studied in isolation — stripped of the living context that shapes their behavior and their resistance. Researchers at Rice University have moved closer to the truth by constructing a three-dimensional bone-like scaffold that includes the immune cells, called macrophages, which naturally inhabit tumors and, paradoxically, shield cancer from the very drugs meant to destroy it. Their findings, centered on osteosarcoma, suggest that the persistent gap between promising lab results and clinical failure is not a mystery of chemistry but o
Futurity: Research News
· Mar 28, 2023
· health
· 3 min read
High
Sourcing: Verified
New bone cancer model reveals how immune cells shield tumors from chemotherapy
◉
Health & Medicine
8951 related articles
FDA Approves Pancreatic Cancer Drug That May Extend Patient Survival
CBS News · 100% match
American Doctor Faces Ebola Crisis at Congo Hospital
Google News · 99% match
At-home flu vaccine now available in 34 states, removing barriers to v…
The Mercury News · 99% match
American doctor in Congo confirmed with Ebola, transferred to Germany …
CBS News · 99% match
Climate, ecology and urbanization create perfect storm for zoonotic di…
news.cgtn.com · 99% match
Related Coverage
BBC News · Sep 04
UK new-build crisis: defects, mould force families from homes as ombudsman complaints triple
Dozens of UK homebuyers report serious defects in new-build properties including mould, structural issues, and damp. Com…
The Guardian · Sep 04 New Zealand becomes second nation to approve MDMA for severe PTSD treatmentNew Zealand's Medsafe approved two psychiatrists to prescribe pharmaceutical-grade MDMA for severe PTSD, making it only …
Insurance Business · Sep 04 Intact Insurance Defeats Chronic Pain Claim Under Ontario's Minor Injury CapA Licence Appeal Tribunal rejected a claimant's attempt to exceed Ontario's $3,500 minor injury cap following a 2023 car…
News-Medical · Sep 04 Study identifies how prednisone impairs bone health in children with muscular dystrophyResearch identifies blood proteins explaining how prednisone, while treating Duchenne muscular dystrophy, impairs childh…
Bias & Framing
⚖
Research-focused article presenting Rice University's 3D tumor model study with neutral scientific framing and minimal bias signals.
Bias Direction
center
Confidence
HIGH
Straightforward scientific reporting emphasizing methodological innovation and practical applications. Uses expert attribution and peer-reviewed publication credibility to establish authority.
Patient or survivor perspectives on treatment outcomes
Pharmaceutical industry viewpoints on drug development challenges
Competing research approaches or alternative tumor modeling methods
Timeline or cost comparisons for implementation of new model
Potential limitations or criticisms of the 3D model approach
Geopolitical Impact
🌎
Rice University develops advanced 3D tumor model to improve cancer drug testing; primarily a medical research advancement with no direct geopolitical implications.
Escalation Risk
low
Confidence
HIGH
Economic Lens
📈
Rice University's 3D tumor model reveals macrophages shield osteosarcoma from chemotherapy, enabling personalized cancer treatment development and improving drug efficacy prediction in clinical settings.
Market Signal
bullish
Confidence
MED
Pharmaceutical and biotechnology
Medical devices and diagnostics
Healthcare and oncology services
Research and development
Patients with osteosarcoma and other cancers may benefit from more effective, personalized treatment options with improved survival rates and reduced unnecessary chemotherapy exposure, though benefits remain years away from clinical availability.
FDA may accelerate approval pathways for cancer drugs validated through advanced 3D modeling. Research funding agencies may prioritize biomimetic tumor models. Healthcare systems may adopt personalized medicine protocols based on tumor microenvironment analysis.